Amphastar Pharmaceuticals is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient (API) products. Co.'s reportable segments are: finished pharmaceutical products, which manufactures, markets and distributes Primatene Mist®, glucagon, enoxaparin, naloxone, phytonadione, lidocaine, epinephrine, various critical and non-critical care drugs; and API, which manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development. We show 39 historical shares outstanding datapoints in our AMPH shares outstanding history coverage, used to compute AMPH market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing AMPH market cap history over the course of time is important for investors
interested in comparing AMPH's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of AMPH versus a peer is one thing; comparing
AMPH market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like AMPH can fluctuate over the course of history.
With this page we aim to empower investors researching AMPH by allowing them to research the AMPH market cap history. |
Free AMPH Email Alerts:
Video: The Importance of Market Cap
